AI Article Synopsis
- Esophagogastroduodenoscopy (EGD) is suggested for patients with typical GERD symptoms who do not respond to proton pump inhibitors, to assess for erosive disease and ensure there are no other conditions.
- The utility of EGD is uncertain for diagnosing laryngopharyngeal reflux (LPR), with ambulatory reflux monitoring being the current standard for such evaluations.
- This study aimed to examine endoscopic findings in patients with chronic laryngeal symptoms, compare results between those with and without esophageal reflux symptoms, and investigate the link between endoscopic results and GERD diagnosed through reflux monitoring.
Article Abstract
Esophagogastroduodenoscopy (EGD) is recommended in patients with typical gastroesophageal reflux disease (GERD) symptoms (heartburn, regurgitation, chest pain) in the setting of proton pump inhibitor (PPI) nonresponse. EGD evaluates for erosive disease, assesses antireflux barrier integrity, excludes non-GERD conditions, and, in the absence of erosive findings, is followed by reflux testing. The diagnostic utility of EGD is less clear in the evaluation for laryngopharyngeal reflux (LPR), and the current reference standard is ambulatory reflux monitoring. This study of patients referred for evaluation of chronic laryngeal symptoms had the following aims: (1) to characterize endoscopic findings, (2) to discern whether findings differed between patients with or without concomitant esophageal reflux symptoms, and (3) to measure the association between endoscopic findings and objective GERD on ambulatory reflux monitoring.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11266523 | PMC |
| http://dx.doi.org/10.1016/j.cgh.2024.01.012 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!